Your browser doesn't support javascript.
loading
Toward Therapeutic Drug Monitoring of Lenalidomide in Hematological Malignancy? Results of an Observational Study of the Exposure-Safety Relationship.
Song, Zaiwei; Ma, Lan; Bao, Li; Ma, Yi; Yang, Ping; Jiang, Dan; Liu, Aijun; Zhang, Lu; Li, Yan; Cheng, Yinchu; Dong, Fei; Zhao, Rongsheng; Jing, Hongmei.
Afiliación
  • Song Z; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
  • Ma L; Therapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, China.
  • Bao L; Department of Hematology, Peking University Third Hospital, Beijing, China.
  • Ma Y; Department of Hematology, Beijing Jishuitan Hospital, Beijing, China.
  • Yang P; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
  • Jiang D; Therapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, China.
  • Liu A; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
  • Zhang L; Therapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, China.
  • Li Y; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
  • Cheng Y; Therapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, China.
  • Dong F; Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
  • Zhao R; Department of Hematology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Jing H; Department of Hematology, Peking University Third Hospital, Beijing, China.
Front Pharmacol ; 13: 931495, 2022.
Article en En | MEDLINE | ID: mdl-35814199

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article